EGFR Mutations Status For Non-Small-Cell Lung Cancer Patients

Volume 26, Number 5 (2016)

Ieva Mirskytė, Jūratė Kasnauskienė, Alvydas Česas, Loreta Radvinskienė Abstract With the advent of the molecular-targeted therapy, rapid progress has been made in the treatment of advanced or recurrent non-small-cell lung cancer (NSCLC). EGFR mutations detection in tumor is important to determine an appropriate treatment of EGFR TK inhibitors. We investigated EGFR mutation status for patients…

Locally Advanced or Metastatic Lung Adenocarcinomas with Egfr Mutantions. Treatment Experience and Advers Events

Volume 24, Number 5(96) (2014)

Alvydas Česas, Aušra Bankauskaitė, Jolanta Česienė, Jūratė Kasnauskienė Abstract Non-small-cell lung cancer (NSCLC) remains the leading causeof cancer-related death. Platinum-based doublet chemotherapyhas been a standard for patients with advanced stage disease.Improvements in overall survival and quality of life have beenmodest. Over the past decade, a large number of studies havebeen published that aimed to target…